Company: TNRSF
Filing Date: 2025-02-21
Form Type: 6-K
Source: 0001171843-25-000987
Chunk: 55

Company: TENARIS SA
Filing Date: 2025-02-21
Form: 6-K
Chunk 55
---
 Indonesia    |     |      |    911 |     |      |  1,573 |     |      |    495 |
| Colombia     |     |      |    893 |     |      |  1,112 |     |      |  1,183 |
| Saudi Arabia |     |      |    759 |     |      |    849 |     |      |    427 |
| Other        |     |      |  1,247 |     |      |  1,193 |     |      |    928 |
|              |     |      | 25,874 |     |      | 29,134 |     |      | 25,292 |

#### 5Impairment charge
Tenaris conducts regular assessments of the carrying values of its assets.
The recoverable value is based on the value in use. The main key assumptions used in estimating the value in use are discount rate, growth
rate and competitive, economic and regulatory factors applied to determine cash flow projections, such as oil and gas prices, average
number of active oil and gas drilling rigs (rig count) and raw material costs.

In December 2024, even though the Company did not identify any impairment
indicators, it conducted impairment tests for the CGUs with goodwill in their carrying amounts and no impairment charges were recorded.
The main discount rates used were in a range between 13.4% and 18.2% and a nominal growth rate (which includes mainly the inflation impact
on prices and costs) of 2% was considered. For the CGUs carrying goodwill, a reasonably possible change in key assumptions would not cause
the carrying amount to exceed its recoverable amount.

In December 2023, considering that the recoverable amount of the CGUs obtained
in prior years' tests and that the assets and liabilities making up those units had not changed significantly, nor the key assumptions
mentioned above, the Company concluded that impairment tests for previous years were still valid. In addition, the Company had considered
the impact of updating the main discount rates, applying rates in a range between 12.5% and 21.4% for the CGUs under analysis. In 2023,
a nominal growth rate (which included mainly the inflation impact on prices and costs) of 2% was considered. Based on the facts mentioned
above, the Company did not recognize any impairment charges for the year 2023.

In December 2022